Variant report
Variant | esv3402348 |
---|---|
Chromosome Location | chr3:20918798-20920796 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:20920030..20922787-chr3:20928844..20930529,2 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs62236045 | chr3:20919615-20919616 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs563557788 | chr3:20919635-20919636 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs575287530 | chr3:20919636-20919637 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs545903635 | chr3:20919653-20919654 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs7639421 | chr3:20919667-20919668 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs532222789 | chr3:20919695-20919696 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs182788035 | chr3:20919718-20919719 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs559632817 | chr3:20919727-20919728 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs529959300 | chr3:20919737-20919738 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs533638536 | chr3:20919742-20919743 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs188725713 | chr3:20919789-20919790 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs569550369 | chr3:20919893-20919894 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs537099777 | chr3:20919896-20919897 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs4549291 | chr3:20919920-20919921 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs534467146 | chr3:20919929-20919930 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs535269353 | chr3:20919941-20919942 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs554520070 | chr3:20919944-20919945 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs575051720 | chr3:20919953-20919954 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs535780248 | chr3:20919966-20919967 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs557282698 | chr3:20919978-20919979 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs193056619 | chr3:20920000-20920001 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs573749169 | chr3:20920024-20920025 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs567044385 | chr3:20920028-20920029 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs545891348 | chr3:20920070-20920071 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs35637371 | chr3:20920073-20920074 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs554690423 | chr3:20920086-20920087 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs73819207 | chr3:20920133-20920134 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs144307757 | chr3:20920199-20920200 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs559306633 | chr3:20920222-20920223 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs116643719 | chr3:20920234-20920235 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs529950723 | chr3:20920327-20920328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs541764795 | chr3:20920366-20920367 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs563262289 | chr3:20920376-20920377 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs536639090 | chr3:20920393-20920394 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs73185085 | chr3:20920399-20920400 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs115565629 | chr3:20920403-20920404 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs35773535 | chr3:20920423-20920424 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs570530384 | chr3:20920425-20920426 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs73819208 | chr3:20920454-20920455 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs145544048 | chr3:20920463-20920464 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs547127676 | chr3:20920483-20920484 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs112722972 | chr3:20920537-20920538 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Breast cancer | 17133270 | CNVD |
Developmental delay | 21147756 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 20688739 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:20919600-20920600 | Enhancers | Fetal Kidney | kidney |